ArticleNPJ vaccines2024

MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans.

Leonie Mayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.